Positron emission tomography in lung cancer

Area of Science:

• Oncology
• Nuclear Medicine
• Radiology

Background:

• Lung carcinoma is a leading cause of cancer mortality worldwide.
• Positron emission tomography (PET) has demonstrated clinical utility and cost-effectiveness in lung cancer management.
• Established applications include characterizing pulmonary nodules and preoperative staging.

Purpose of the Study:

• To review current data supporting PET use in lung cancer.
• To explore evolving indications for PET in lung cancer.
• To discuss future prospects of PET imaging in lung cancer.

Main Methods:

• Review of existing literature on PET in lung cancer.
• Analysis of established and emerging applications of PET.
• Exploration of novel tracer techniques and combined imaging modalities.

Main Results:

• PET is effective for characterizing solitary pulmonary nodules and preoperative staging.
• Evolving applications include recurrence detection, treatment response assessment, radiotherapy planning, and prognosis.
• Interest is growing in combined anatomic/metabolic imaging and gene expression imaging.

Conclusions:

• PET imaging is a crucial tool in the current management of lung cancer.
• Future advancements in PET tracers and techniques promise enhanced diagnostic and therapeutic strategies for lung cancer.
• PET plays a significant role in the evolving landscape of lung cancer care.